B, S., X, L., & H, J. (2024, August). Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up. Clinical, Cosmetic and Investigational Dermatology.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)B, Song, Liu X, و Jin H. "Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up." Clinical, Cosmetic and Investigational Dermatology Aug. 2024.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)B, Song, et al. "Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up." Clinical, Cosmetic and Investigational Dermatology, Aug. 2024.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.
